Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 284


Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.

Markham MJ, Wachter K, Agarwal N, Bertagnolli MM, Chang SM, Dale W, Diefenbach CSM, Rodriguez-Galindo C, George DJ, Gilligan TD, Harvey RD, Johnson ML, Kimple RJ, Knoll MA, LoConte N, Maki RG, Meisel JL, Meyerhardt JA, Pennell NA, Rocque GB, Sabel MS, Schilsky RL, Schneider BJ, Tap WD, Uzzo RG, Westin SN.

J Clin Oncol. 2020 Feb 4:JCO1903141. doi: 10.1200/JCO.19.03141. [Epub ahead of print]


Treatment of Childhood Nasopharyngeal Carcinoma With Induction Chemotherapy and Concurrent Chemoradiotherapy: Results of the Children's Oncology Group ARAR0331 Study.

Rodriguez-Galindo C, Krailo MD, Krasin MJ, Huang L, McCarville MB, Hicks J, Pashankar F, Pappo AS.

J Clin Oncol. 2019 Dec 10;37(35):3369-3376. doi: 10.1200/JCO.19.01276. Epub 2019 Sep 25.


Delayed Enucleation With Neoadjuvant Chemotherapy in Advanced Intraocular Unilateral Retinoblastoma: AHOPCA II, a Prospective, Multi-Institutional Protocol in Central America.

Luna-Fineman S, Chantada G, Alejos A, Amador G, Barnoya M, Castellanos ME, Fu L, Fuentes-Alabi S, Girón V, Goenz MA, Maldonado C, Méndez G, Morales RA, Ortiz R, Sanchez G, Wilson M, Rodríguez-Galindo C.

J Clin Oncol. 2019 Nov 1;37(31):2875-2882. doi: 10.1200/JCO.18.00141. Epub 2019 Sep 19.


Cost-benefit analysis of implementing a pediatric early warning system at a pediatric oncology hospital in a low-middle income country.

Agulnik A, Antillon-Klussmann F, Soberanis Vasquez DJ, Arango R, Moran E, Lopez V, Rodriguez-Galindo C, Bhakta N.

Cancer. 2019 Nov 15;125(22):4052-4058. doi: 10.1002/cncr.32436. Epub 2019 Aug 22.


Correlation Between MYCN Gene Status and MYCN Protein Expression in Neuroblastoma: A Pilot Study To Propose the Use of MYCN Immunohistochemistry in Limited-Resource Areas.

Santiago T, Tarek N, Boulos F, Hayes C, Jeha S, Raimondi S, Rodriguez-Galindo C.

J Glob Oncol. 2019 Jul;5:1-7. doi: 10.1200/JGO.19.00135.


α-Fetoprotein as a predictor of outcome for children with germ cell tumors: A report from the Malignant Germ Cell International Consortium.

O'Neill AF, Xia C, Krailo MD, Shaikh F, Pashankar FD, Billmire DF, Olson TA, Amatruda JF, Villaluna D, Huang L, Malogolowkin M, Rodriguez-Galindo C, Frazier AL.

Cancer. 2019 Oct 15;125(20):3649-3656. doi: 10.1002/cncr.32363. Epub 2019 Jul 29.


Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: Recommendations from the North American Consortium for Histiocytosis (NACHO).

Jordan MB, Allen CE, Greenberg J, Henry M, Hermiston ML, Kumar A, Hines M, Eckstein O, Ladisch S, Nichols KE, Rodriguez-Galindo C, Wistinghausen B, McClain KL.

Pediatr Blood Cancer. 2019 Nov;66(11):e27929. doi: 10.1002/pbc.27929. Epub 2019 Jul 24. Review.


Things that matter: Adolescent and young adult patients' priorities during cancer care.

Graetz D, Fasciano K, Rodriguez-Galindo C, Block SD, Mack JW.

Pediatr Blood Cancer. 2019 Sep;66(9):e27883. doi: 10.1002/pbc.27883. Epub 2019 Jun 17.


Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial.

Katzenstein HM, Langham MR, Malogolowkin MH, Krailo MD, Towbin AJ, McCarville MB, Finegold MJ, Ranganathan S, Dunn S, McGahren ED, Tiao GM, O'Neill AF, Qayed M, Furman WL, Xia C, Rodriguez-Galindo C, Meyers RL.

Lancet Oncol. 2019 May;20(5):719-727. doi: 10.1016/S1470-2045(18)30895-7. Epub 2019 Apr 8. Erratum in: Lancet Oncol. 2019 May;20(5):e243.


Maintenance treatment with trofosfamide in patients with primary bone ewing sarcoma - single center experience.

Raciborska A, Bilska K, Rodriguez-Galindo C.

Dev Period Med. 2019;23(1):39-44.


Clinical responses and persistent BRAF V600E+ blood cells in children with LCH treated with MAPK pathway inhibition.

Eckstein OS, Visser J, Rodriguez-Galindo C, Allen CE; NACHO-LIBRE Study Group.

Blood. 2019 Apr 11;133(15):1691-1694. doi: 10.1182/blood-2018-10-878363. Epub 2019 Feb 4. No abstract available.


Clinical Cancer Advances 2019: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.

Pal SK, Miller MJ, Agarwal N, Chang SM, Chavez-MacGregor M, Cohen E, Cole S, Dale W, Magid Diefenbach CS, Disis ML, Dreicer R, Graham DL, Henry NL, Jones J, Keedy V, Klepin HD, Markham MJ, Mittendorf EA, Rodriguez-Galindo C, Sabel MS, Schilsky RL, Sznol M, Tap WD, Westin SN, Johnson BE.

J Clin Oncol. 2019 Apr 1;37(10):834-849. doi: 10.1200/JCO.18.02037. Epub 2019 Jan 31. No abstract available.


Childhood cancer burden: a review of global estimates.

Bhakta N, Force LM, Allemani C, Atun R, Bray F, Coleman MP, Steliarova-Foucher E, Frazier AL, Robison LL, Rodriguez-Galindo C, Fitzmaurice C.

Lancet Oncol. 2019 Jan;20(1):e42-e53. doi: 10.1016/S1470-2045(18)30761-7. Review.


Global Access to Essential Medicines for Childhood Cancer: A Cross-Sectional Survey.

Cohen P, Friedrich P, Lam C, Jeha S, Metzger ML, Qaddoumi I, Naidu P, Faughnan L, Rodriguez-Galindo C, Bhakta N.

J Glob Oncol. 2018 Dec;4:1-11. doi: 10.1200/JGO.18.00150.


Detection of Relapse by Tumor Markers Versus Imaging in Children and Adolescents With Nongerminomatous Malignant Germ Cell Tumors: A Report From the Children's Oncology Group.

Fonseca A, Xia C, Lorenzo AJ, Krailo M, Olson TA, Pashankar F, Malogolowkin MH, Amatruda JF, Billmire DF, Rodriguez-Galindo C, Frazier AL, Shaikh F.

J Clin Oncol. 2019 Feb 10;37(5):396-402. doi: 10.1200/JCO.18.00790. Epub 2018 Dec 21.


Salvage regimens for pediatric patients with relapsed nasopharyngeal carcinoma.

DeRenzo C, Lam C, Rodriguez-Galindo C, Rapkin L, Gottschalk S, Venkatramani R.

Pediatr Blood Cancer. 2019 Jan;66(1):e27469. doi: 10.1002/pbc.27469. Epub 2018 Oct 14.


Spatial trends in congenital malformations and stream water chemistry in Southern Brazil.

Ibañez HC, Melanda VS, Gerber VKQ, Licht OAB, Ibañez MVC, Aguiar Júnior TR, Mello RG, Komechen H, Andrade DP, Picharski GL, Figueiredo DPG, Pianovski MAD, Figueiredo MMO, Custódio G, Parise IZS, Castilho LM, Paraizo MM, Edinger C, Fiori CMCM, Pedrini H, Kiesel Filho N, Fabro ALMR, Fachin RD, Ogradowski KRP, Parise GA, Saldiva PHN, Legal EF, Rosati R, Rodriguez-Galindo C, Ribeiro RC, Zambetti GP, Lalli E, Figueiredo BC.

Sci Total Environ. 2019 Feb 10;650(Pt 1):1278-1291. doi: 10.1016/j.scitotenv.2018.09.061. Epub 2018 Sep 5.


Improving Immunohistochemistry Capability for Pediatric Cancer Care in the Central American and Caribbean Region: A Report From the AHOPCA Pathology Working Group.

Santiago T, Hayes C, Polanco AC, Miranda L, Aybar A, Gomero B, Orellana E, Anglade F, Toledo González ML, Ruiz E, Espino-Durán M, Rodriguez-Galindo C, Metzger ML.

J Glob Oncol. 2018 Sep;4:1-9. doi: 10.1200/JGO.17.00187. Review.


Global efforts toward the cure of childhood acute lymphoblastic leukaemia.

Pui CH, Yang JJ, Bhakta N, Rodriguez-Galindo C.

Lancet Child Adolesc Health. 2018 Jun;2(6):440-454. doi: 10.1016/S2352-4642(18)30066-X. Epub 2018 Mar 30. Review. Erratum in: Lancet Child Adolesc Health. 2018 Nov;2(11):e25.


The Toronto Guidelines: a practical means for childhood cancer staging.

Bhakta N, Rodriguez-Galindo C.

Lancet Child Adolesc Health. 2018 Mar;2(3):158-159. doi: 10.1016/S2352-4642(18)30024-5. Epub 2018 Feb 3. No abstract available.


Long-term remission of refractory Rosai-Dorfman disease after salvage therapy with clofarabine in an adult patient.

Hinterleitner C, Steurer M, Dörfel D, Heitmann J, Kreisselmeier KP, Müller K, Kopp HG, Wirths S, Haap M, de Fend LQ, Horger M, Rodriguez-Galindo C, Kanz L, Müller MR.

Ann Hematol. 2019 Jan;98(1):227-230. doi: 10.1007/s00277-018-3421-7. Epub 2018 Jul 6. No abstract available.


Is carboplatin-based chemotherapy as effective as cisplatin-based chemotherapy in the treatment of advanced-stage dysgerminoma in children, adolescents and young adults?

Shah R, Xia C, Krailo M, Amatruda JF, Arul SG, Billmire DF, Brady WE, Covens A, Gershenson DM, Hale JP, Hurteau J, Murray MJ, Nicholson JC, Olson TA, Pashankar F, Rodriguez-Galindo C, Shaikh F, Stark D, Frazier AL, Stoneham S.

Gynecol Oncol. 2018 Aug;150(2):253-260. doi: 10.1016/j.ygyno.2018.05.025. Epub 2018 Jun 5.


Comparison of carboplatin versus cisplatin in the treatment of paediatric extracranial malignant germ cell tumours: A report of the Malignant Germ Cell International Consortium.

Frazier AL, Stoneham S, Rodriguez-Galindo C, Dang H, Xia C, Olson TA, Murray MJ, Amatruda JF, Shaikh F, Pashankar F, Billmire D, Krailo M, Stark D, Brougham MFH, Nicholson JC, Hale JP.

Eur J Cancer. 2018 Jul;98:30-37. doi: 10.1016/j.ejca.2018.03.004. Epub 2018 May 31.


Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.

Abla O, Jacobsen E, Picarsic J, Krenova Z, Jaffe R, Emile JF, Durham BH, Braier J, Charlotte F, Donadieu J, Cohen-Aubart F, Rodriguez-Galindo C, Allen C, Whitlock JA, Weitzman S, McClain KL, Haroche J, Diamond EL.

Blood. 2018 Jun 28;131(26):2877-2890. doi: 10.1182/blood-2018-03-839753. Epub 2018 May 2. Review.


Treatment of refractory germ cell tumors in children with paclitaxel, ifosfamide, and carboplatin: A report from the Children's Oncology Group AGCT0521 study.

Pashankar F, Frazier AL, Krailo M, Xia C, Pappo AS, Malogolowkin M, Olson TA, Rodriguez-Galindo C.

Pediatr Blood Cancer. 2018 Aug;65(8):e27111. doi: 10.1002/pbc.27111. Epub 2018 Apr 26.


Pediatric Early Warning Systems aid in triage to intermediate versus intensive care for pediatric oncology patients in resource-limited hospitals.

Agulnik A, Nadkarni A, Mora Robles LN, Soberanis Vasquez DJ, Mack R, Antillon-Klussmann F, Rodriguez-Galindo C.

Pediatr Blood Cancer. 2018 Aug;65(8):e27076. doi: 10.1002/pbc.27076. Epub 2018 Apr 10.


CNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH-associated neurodegeneration and mass lesions.

McClain KL, Picarsic J, Chakraborty R, Zinn D, Lin H, Abhyankar H, Scull B, Shih A, Lim KPH, Eckstein O, Lubega J, Peters TL, Olea W, Burke T, Ahmed N, Hicks MJ, Tran B, Jones J, Dauser R, Jeng M, Baiocchi R, Schiff D, Goldman S, Heym KM, Wilson H, Carcamo B, Kumar A, Rodriguez-Galindo C, Whipple NS, Campbell P, Murdoch G, Kofler J, Heales S, Malone M, Woltjer R, Quinn JF, Orchard P, Kruer MC, Jaffe R, Manz MG, Lira SA, Parsons DW, Merad M, Man TK, Allen CE.

Cancer. 2018 Jun 15;124(12):2607-2620. doi: 10.1002/cncr.31348. Epub 2018 Apr 6.


Displaced children with cancer in Lebanon: A sustained response to an unprecedented crisis.

Saab R, Jeha S, Khalifeh H, Zahreddine L, Bayram L, Merabi Z, Abboud M, Muwakkit S, Tarek N, Rodriguez-Galindo C, El Solh H.

Cancer. 2018 Apr 1;124(7):1464-1472. doi: 10.1002/cncr.31273. Epub 2018 Feb 28.


Clinical and mutational spectrum of highly differentiated, paired box 3:forkhead box protein o1 fusion-negative rhabdomyosarcoma: A report from the Children's Oncology Group.

Teot LA, Schneider M, Thorner AR, Tian J, Chi YY, Ducar M, Lin L, Wlodarski M, Grier HE, Fletcher CDM, van Hummelen P, Skapek SX, Hawkins DS, Wagers AJ, Rodriguez-Galindo C, Hettmer S.

Cancer. 2018 May 1;124(9):1973-1981. doi: 10.1002/cncr.31286. Epub 2018 Feb 20.


Adolescents and Young Adults With a "Rare" Cancer: Getting Past Semantics to Optimal Care for Patients With Germ Cell Tumors.

Stoneham SJ, Hale JP, Rodriguez-Galindo C, Dang H, Olson T, Murray M, Amatruda JF, Thornton C, Arul GS, Billmire D, Krailo M, Stark D, Covens A, Hurteau J, Stenning S, Nicholson JC, Gershenson D, Frazier AL.

Oncologist. 2018 Feb;23(2):272. doi: 10.1634/theoncologist.2014-0009erratum. No abstract available.


Clinical Cancer Advances 2018: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology.

Heymach J, Krilov L, Alberg A, Baxter N, Chang SM, Corcoran RB, Dale W, DeMichele A, Magid Diefenbach CS, Dreicer R, Epstein AS, Gillison ML, Graham DL, Jones J, Ko AH, Lopez AM, Maki RG, Rodriguez-Galindo C, Schilsky RL, Sznol M, Westin SN, Burstein H.

J Clin Oncol. 2018 Apr 1;36(10):1020-1044. doi: 10.1200/JCO.2017.77.0446. Epub 2018 Jan 30.


Gonadal dysgenesis is associated with worse outcomes in patients with ovarian nondysgerminomatous tumors: A report of the Children's Oncology Group AGCT 0132 study.

Dicken BJ, Billmire DF, Krailo M, Xia C, Shaikh F, Cullen JW, Olson TA, Pashankar F, Malogolowkin MH, Amatruda JF, Rescorla FJ, Egler RA, Ross JH, Rodriguez-Galindo C, Frazier AL.

Pediatr Blood Cancer. 2018 Apr;65(4). doi: 10.1002/pbc.26913. Epub 2017 Dec 29.


Early death in pediatric cancer: remaining questions and next steps.

Furutani E, Rodriguez-Galindo C, Green AL.

Oncotarget. 2017 Nov 1;8(57):96478-96479. doi: 10.18632/oncotarget.22257. eCollection 2017 Nov 14. No abstract available.


Racial and Ethnic Disparities in the Incidence of Pediatric Extracranial Embryonal Tumors.

Friedrich P, Itriago E, Rodriguez-Galindo C, Ribeiro K.

J Natl Cancer Inst. 2017 Oct 1;109(10). doi: 10.1093/jnci/djx050.


Identification of Clinical and Biologic Correlates Associated With Outcome in Children With Adrenocortical Tumors Without Germline TP53 Mutations: A St Jude Adrenocortical Tumor Registry and Children's Oncology Group Study.

Pinto EM, Rodriguez-Galindo C, Pounds SB, Wang L, Clay MR, Neale G, Garfinkle EAR, Lam CG, Levy CF, Pappo AS, Zambetti GP, Ribeiro RC.

J Clin Oncol. 2017 Dec 10;35(35):3956-3963. doi: 10.1200/JCO.2017.74.2460. Epub 2017 Oct 23.


Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors.

Izumchenko E, Paz K, Ciznadija D, Sloma I, Katz A, Vasquez-Dunddel D, Ben-Zvi I, Stebbing J, McGuire W, Harris W, Maki R, Gaya A, Bedi A, Zacharoulis S, Ravi R, Wexler LH, Hoque MO, Rodriguez-Galindo C, Pass H, Peled N, Davies A, Morris R, Hidalgo M, Sidransky D.

Ann Oncol. 2017 Oct 1;28(10):2595-2605. doi: 10.1093/annonc/mdx416.


Evaluation and treatment of Langerhans cell histiocytosis patients with central nervous system abnormalities: Current views and new vistas.

Yeh EA, Greenberg J, Abla O, Longoni G, Diamond E, Hermiston M, Tran B, Rodriguez-Galindo C, Allen CE, McClain KL; North American Consortium for Histiocytosis.

Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26784. Epub 2017 Sep 25. Review.


Characterization of Pulmonary Metastases in Children With Hepatoblastoma Treated on Children's Oncology Group Protocol AHEP0731 (The Treatment of Children With All Stages of Hepatoblastoma): A Report From the Children's Oncology Group.

O'Neill AF, Towbin AJ, Krailo MD, Xia C, Gao Y, McCarville MB, Meyers RL, McGahren ED, Tiao GM, Dunn SP, Langham MR Jr, Weldon CB, Finegold MJ, Ranganathan S, Furman WL, Malogolowkin M, Rodriguez-Galindo C, Katzenstein HM.

J Clin Oncol. 2017 Oct 20;35(30):3465-3473. doi: 10.1200/JCO.2017.73.5654. Epub 2017 Sep 11.


Validation of a pediatric early warning system for hospitalized pediatric oncology patients in a resource-limited setting.

Agulnik A, Méndez Aceituno A, Mora Robles LN, Forbes PW, Soberanis Vasquez DJ, Mack R, Antillon-Klussmann F, Kleinman M, Rodriguez-Galindo C.

Cancer. 2017 Dec 15;123(24):4903-4913. doi: 10.1002/cncr.30951. Epub 2017 Sep 7.


Influence of early phase clinical trial enrollment on patterns of end-of-life care for children with advanced cancer.

Ananth P, Monsereenusorn C, Ma C, Al-Sayegh H, Wolfe J, Rodriguez-Galindo C.

Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26748. Epub 2017 Aug 3.


Improved outcomes after successful implementation of a pediatric early warning system (PEWS) in a resource-limited pediatric oncology hospital.

Agulnik A, Mora Robles LN, Forbes PW, Soberanis Vasquez DJ, Mack R, Antillon-Klussmann F, Kleinman M, Rodriguez-Galindo C.

Cancer. 2017 Aug 1;123(15):2965-2974. doi: 10.1002/cncr.30664. Epub 2017 Apr 25.


Death Within 1 Month of Diagnosis in Childhood Cancer: An Analysis of Risk Factors and Scope of the Problem.

Green AL, Furutani E, Ribeiro KB, Rodriguez Galindo C.

J Clin Oncol. 2017 Apr 20;35(12):1320-1327. doi: 10.1200/JCO.2016.70.3249. Epub 2017 Mar 6.


Contribution of the TP53 R337H mutation to the cancer burden in southern Brazil: Insights from the study of 55 families of children with adrenocortical tumors.

Mastellaro MJ, Seidinger AL, Kang G, Abrahão R, Miranda ECM, Pounds SB, Cardinalli IA, Aguiar SS, Figueiredo BC, Rodriguez-Galindo C, Brandalise SR, Yunes JA, Barros-Filho AA, Ribeiro RC.

Cancer. 2017 Aug 15;123(16):3150-3158. doi: 10.1002/cncr.30703. Epub 2017 Apr 7.


Open letter to Lady Scotland.

Weller D, Lodge M, Eden T, Fleming D, Bouffet E, Schocken C, Magrath I, Rosser J, Joubert E, Rodriguez-Galindo C, Denny L, Vallejo-Auste C; signatories.

Lancet Oncol. 2017 Apr;18(4):e194. doi: 10.1016/S1470-2045(17)30205-X. No abstract available.


Malignant glomus tumors of the head and neck in children and adults: Evaluation and management.

Wolter NE, Adil E, Irace AL, Werger A, Perez-Atayde AR, Weldon C, Orbach DB, Rodriguez-Galindo C, Rahbar R.

Laryngoscope. 2017 Dec;127(12):2873-2882. doi: 10.1002/lary.26550. Epub 2017 Mar 14. Review.


Reduced and Compressed Cisplatin-Based Chemotherapy in Children and Adolescents With Intermediate-Risk Extracranial Malignant Germ Cell Tumors: A Report From the Children's Oncology Group.

Shaikh F, Cullen JW, Olson TA, Pashankar F, Malogolowkin MH, Amatruda JF, Villaluna D, Krailo M, Billmire DF, Rescorla FJ, Egler RA, Dicken BJ, Ross JH, Schlatter M, Rodriguez-Galindo C, Frazier AL.

J Clin Oncol. 2017 Apr 10;35(11):1203-1210. doi: 10.1200/JCO.2016.67.6544. Epub 2017 Feb 27.


Delivery of radiation therapy in resource-limited settings: A pilot quality assessment study.

Power-Hays A, Friedrich P, Fernandez G, Cruz NA, Marcus K, Rodriguez-Galindo C, Collado L.

Pediatr Blood Cancer. 2017 Aug;64(8). doi: 10.1002/pbc.26480. Epub 2017 Feb 22.


Upfront window vincristine/irinotecan treatment of high-risk hepatoblastoma: A report from the Children's Oncology Group AHEP0731 study committee.

Katzenstein HM, Furman WL, Malogolowkin MH, Krailo MD, McCarville MB, Towbin AJ, Tiao GM, Finegold MJ, Ranganathan S, Dunn SP, Langham MR, McGahren ED, Rodriguez-Galindo C, Meyers RL.

Cancer. 2017 Jun 15;123(12):2360-2367. doi: 10.1002/cncr.30591. Epub 2017 Feb 17.


Ocular Salvage and Vision Preservation Using a Topotecan-Based Regimen for Advanced Intraocular Retinoblastoma.

Brennan RC, Qaddoumi I, Mao S, Wu J, Billups CA, Stewart CF, Hoehn ME, Rodriguez-Galindo C, Wilson MW.

J Clin Oncol. 2017 Jan;35(1):72-77. Epub 2016 Oct 31.


Systemic neoadjuvant chemotherapy for Group B intraocular retinoblastoma (ARET0331): A report from the Children's Oncology Group.

Friedman DL, Krailo M, Villaluna D, Gombos D, Langholz B, Jubran R, Shields C, Murphree L, O'Brien J, Kessel S, Rodriguez-Galindo C, Chintagumpala M, Meadows AT.

Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26394. Epub 2016 Dec 26.

Supplemental Content

Loading ...
Support Center